Nicotinell Lakrits (Nicotine Polacrilex)

Nicotine polacrilex is a polymer‑bound nicotine that releases the active ingredient slowly when placed against the cheek. The nicotine is absorbed through the buccal lining, binds to nicotinic acetylcholine receptors in the brain, and partially stimulates them. This mimics the effect of smoking enough to lessen cravings while allowing the user to taper nicotine exposure over time.

The appropriate dose of Nicotinell Lakrits is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and not exceed the recommended number of tablets per day.

Safety data for nicotine polacrilex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nicotinell Lakrits. The prescriber may recommend alternative cessation strategies if concerns arise.

To order Nicotinell Lakrits, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and any necessary import documentation.

Nicotinell Lakrits delivers nicotine via a buccal tablet, offering a discreet, non‑inhaled option compared with patches, gums, or lozenges. Its polymer‑bound nicotine provides a steady release, which can result in fewer spikes in nicotine levels than some gums or lozenges. Choice of product depends on patient preference, tolerability, and specific cessation plan.

Nicotinell Lakrits should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures, which could affect tablet integrity and nicotine stability.

The tablet is placed between the gum and cheek, allowing it to dissolve slowly. Users should avoid chewing or swallowing the tablet whole. The tablet should remain in place until it has fully dissolved, typically a few minutes, after which the user can replace it with a new one as directed by the prescriber.

Serious risks, though rare, include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain or palpitations. Users should seek immediate medical attention if they experience any signs of a severe allergic response or persistent chest discomfort while using the product.

Nicotinell Lakrits is not recommended for individuals under 18 years of age, those with known hypersensitivity to nicotine polacrilex or any tablet excipients, and patients with recent myocardial infarction or uncontrolled severe cardiovascular disease unless advised otherwise by a healthcare professional.